Home » Topics » Regulatory

Regulatory
RSS

Indomethacin: antitumor activity and effects on telomerase

Dec. 17, 1997

Z-103 as effective as sulfasalazine in rat model of colitis

Dec. 17, 1997

Astra Merck and P&G to develop OTC formulation of Prilosec for heartburn

Dec. 17, 1997

Oral morphine effective for management of sickle cell pain in children

Dec. 16, 1997

FDA approves new alternative to hysterectomy in women with menorrhagia

Dec. 16, 1997

Pennsaid submitted to FDA for approval

Dec. 16, 1997

Migranal Nasal Spray approved by FDA

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...